These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23586589)
1. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions. Neubert A; Dormann H; Prokosch HU; Bürkle T; Rascher W; Sojer R; Brune K; Criegee-Rieck M Br J Clin Pharmacol; 2013 Sep; 76 Suppl 1(Suppl 1):69-77. PubMed ID: 23586589 [TBL] [Abstract][Full Text] [Related]
2. Supervised signal detection for adverse drug reactions in medication dispensing data. Hoang T; Liu J; Roughead E; Pratt N; Li J Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965 [TBL] [Abstract][Full Text] [Related]
3. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report. Hariraj V; Aziz Z Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567 [TBL] [Abstract][Full Text] [Related]
4. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study. Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department. Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
9. A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation. Lee S; Lee JH; Kim GJ; Kim JY; Shin H; Ko I; Choe S; Kim JH J Med Internet Res; 2022 Oct; 24(10):e35464. PubMed ID: 36201386 [TBL] [Abstract][Full Text] [Related]
10. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137 [TBL] [Abstract][Full Text] [Related]
11. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. Brvar M; Fokter N; Bunc M; Mozina M BMC Clin Pharmacol; 2009 May; 9():8. PubMed ID: 19409112 [TBL] [Abstract][Full Text] [Related]
12. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015. van Hunsel F; de Waal S; Härmark L Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293 [TBL] [Abstract][Full Text] [Related]
13. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system. Filippi-Arriaga F; Aguilera C; Guillén E; Bellas L; Pérez E; Vendrell L; Agustí A; Cereza G Front Pharmacol; 2023; 14():1211786. PubMed ID: 37492089 [No Abstract] [Full Text] [Related]
14. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding. Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146 [TBL] [Abstract][Full Text] [Related]
15. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center. Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL Therapie; 2014; 69(5):395-400. PubMed ID: 25269141 [TBL] [Abstract][Full Text] [Related]
16. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Tandon VR; Mahajan V; Khajuria V; Gillani Z Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314 [TBL] [Abstract][Full Text] [Related]
17. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria. Adisa R; Adeniyi OR; Fakeye TO Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162 [TBL] [Abstract][Full Text] [Related]
18. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Inch J; Watson MC; Anakwe-Umeh S Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729 [TBL] [Abstract][Full Text] [Related]
19. A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective. Hussain R; Hassali MA; Ur Rehman A; Muneswarao J; Atif M; Babar ZU Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349339 [TBL] [Abstract][Full Text] [Related]
20. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project. Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G; Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]